American Shared Hospital Services financial data

Symbol
AMS on NYSE
Industry
Services-Medical Laboratories
Location
601 Montgomery Street, Suite 1112, San Francisco, CA
State of incorporation
California
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 195 % -44.3%
Debt-to-equity 101 % +20.8%
Return On Equity 15.3 % +515%
Return On Assets 8.24 % +465%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.36M shares +1.86%
Common Stock, Shares, Outstanding 6.36M shares +2.35%
Entity Public Float 11.2M USD
Common Stock, Value, Issued 10.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.48M shares +2.3%
Weighted Average Number of Shares Outstanding, Diluted 6.58M shares +3.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.1M USD +13.5%
Cost of Revenue 13.6M USD +16%
Operating Income (Loss) 411K USD -49.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.5M USD +314%
Income Tax Expense (Benefit) 323K USD -40.4%
Net Income (Loss) Attributable to Parent 4.25M USD +566%
Earnings Per Share, Basic 0.67 USD/shares +570%
Earnings Per Share, Diluted 0.66 USD/shares +560%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.2M USD +4.1%
Accounts Receivable, after Allowance for Credit Loss, Current 8.61M USD +83.5%
Assets, Current 25.6M USD +27.7%
Operating Lease, Right-of-Use Asset 631K USD +332%
Intangible Assets, Net (Excluding Goodwill) 78K USD 0%
Goodwill 1.27M USD 0%
Other Assets, Noncurrent 199K USD +424%
Assets 60.8M USD +36.8%
Accounts Payable, Current 859K USD +189%
Employee-related Liabilities, Current 908K USD +20.7%
Contract with Customer, Liability, Current 554K USD
Liabilities, Current 13.3M USD +97.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 1.47M USD +79.1%
Operating Lease, Liability, Noncurrent 1.62M USD +6922%
Liabilities 28.5M USD +52.1%
Retained Earnings (Accumulated Deficit) 7.35M USD +137%
Stockholders' Equity Attributable to Parent 26.5M USD +21.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 32.4M USD +25.7%
Liabilities and Equity 60.8M USD +36.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.87M USD -206%
Net Cash Provided by (Used in) Financing Activities 2.28M USD
Net Cash Provided by (Used in) Investing Activities -1.18M USD -466%
Common Stock, Shares Authorized 10M shares 0%
Common Stock, Shares, Issued 6.36M shares +2.35%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -766K USD -202%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.7M USD +25.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 311K USD +22.9%
Deferred Tax Assets, Valuation Allowance 714K USD +2.44%
Deferred Tax Assets, Gross 1.4M USD +23.5%
Operating Lease, Liability 1.86M USD +1138%
Depreciation 1.27M USD +7.02%
Payments to Acquire Property, Plant, and Equipment 1.18M USD +466%
Lessee, Operating Lease, Liability, to be Paid 2.61M USD +1597%
Operating Lease, Liability, Current 242K USD +90.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 347K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 346K USD +486%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +56.8%
Deferred Income Tax Expense (Benefit) 5K USD -92.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 756K USD +18800%
Lessee, Operating Lease, Liability, to be Paid, Year Three 347K USD
Deferred Tax Assets, Operating Loss Carryforwards 155K USD +11.5%
Unrecognized Tax Benefits 287K USD +3.24%
Lessee, Operating Lease, Liability, to be Paid, Year Four 348K USD
Operating Lease, Payments 131K USD -68.1%
Depreciation, Depletion and Amortization 1.21M USD -1.54%
Deferred Tax Assets, Net of Valuation Allowance 681K USD +57.3%
Share-based Payment Arrangement, Expense 98K USD +28.9%
Interest Expense 1.3M USD +22.8%